Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients

Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Nephrol Renovasc Dis
Hoofdauteurs: Koike, Kiyomi, Fukami, Kei, Kawaguchi, Atsushi, Shimamatsu, Kazumasa, Yamagishi, Sho-ichi, Okuda, Seiya
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822794/
https://ncbi.nlm.nih.gov/pubmed/27099526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S98196
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items